The company's principal activity is the provision of therapies for age-related disease, initially focussing on the treatment of alzheimer's disease. Other potential applications for the company's technology include cataracts, tardive dyskinesia, creutzfeldt-jakob disease (cjd or mad cow disease), motor neuron disease and Parkinson's disease.
